JP Morgan Chase
VTAE

JP Morgan Chase’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

JP Morgan Chase’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-247,830
Closed -$5.18M – 5312
2016
Q3 		$5.18M Sell
247,830
-71,270
-22% -$821K ﹤0.01% 2227
2016
Q2 		$3.44M Buy
319,100
+130,300
+69% +$1.11M ﹤0.01% 2520
2016
Q1 		$1.25M Sell
188,800
-14,829
-7% -$135K ﹤0.01% 2960
2015
Q4 		$3.69M Sell
203,629
-195,164
-49% -$2.69M ﹤0.01% 2408
2015
Q3 		$4.39M Buy
398,793
+158,393
+66% +$1.68M ﹤0.01% 2300
2015
Q2 		$3.46M Sell
240,400
-20,760
-8% -$282K ﹤0.01% 2607
2015
Q1 		$3.06M Buy
261,160
+160,560
+160% +$2.17M ﹤0.01% 2645
2014
Q4 		$1.67M Sell
100,600
-24,400
-20% -$357K ﹤0.01% 3062
2014
Q3 		$953K Buy
+125,000
New +$972K ﹤0.01% 3366

JP Morgan Chase's VTAE Position: Q4 2016 in Review

JP Morgan Chase sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 247,830 shares — an estimated $5.18M sold.

JP Morgan Chase first reported a position in VTAE in Q3 2014 and held it in 9 quarters. The position peaked at $5.18M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • JP Morgan Chase reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 247,830 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $5.18M.
  • JP Morgan Chase first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 9 quarters.
  • JP Morgan Chase's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $5.18M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.